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Abstract
Background: From October 2006 to February 2007, clinical specimens from 452 patients with
symptoms related to respiratory tract infection in the northern region of Taiwan were collected.
Real-time PCR and direct immunofluorescent antibody tests showed that 145 (32%) patients had
influenza B virus infections. Subsequently, nucleotide sequence analyses of both hemagglutinin (HA)
and neuraminidase (NA) genes of 39 isolates were performed. Isolated viruses were antigenically
characterized using hemagglutinin inhibition (HI) test.
Findings: Phylogenetic tree analysis showed that all the isolates belonged to the B reassortant
lineage with HA gene belonged to the B/Victoria/2/87 lineage and the NA gene belonged to the B/
Yamagata/16/88 lineage. In addition, a group of children aged between 6 to 8 years old resided in
Yilan county were infected with a variant strain. Hemagglutinin inhibition (HI) tests confirmed that
all the reassortant influenza B viruses were B/Malaysia/2506/04-like viruses. Pre- and post-
immunized serum samples from 4 normal volunteers inoculated with 2007 influenza vaccine were
evaluated for their HI activity on 6 reassortant B isolates including two variants that we found in
the Yilan county. The results demonstrated that after vaccination, all four vaccinees had at least 4-
fold increases of their HI titers.
Conclusion: The results indicate that the 2006–2007 seasonal influenza vaccine was effective in
stimulating protective immunity against the influenza B variants identified in Yilan county.
Continuous surveillance of emerging influenza B variants in the northern region of Taiwan is
important for the selection of proper vaccine candidate in the future.
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Background
Enveloped orthomyxoviruses have segmented negative-
sense RNA genomes that facilitate new strain develop-
ment via mutations and the reassortment of gene seg-
ments. This genetic instability is responsible for annual
international epidemics and periodic pandemics of influ-
enza infections [1,2]. Influenza viruses are spread by small
airborne droplets expelled while talking, breathing, and
coughing. The most susceptible population is children,
and school-age children are the most common spreaders
of infection [3-7]. Vaccines are thought to be the most
effective modality for influenza control, and phylogenetic
analyses of genes of viruses provide valuable information
for vaccine development and prophylaxis.
Hemagglutinin (HA) and neuraminidase (NA) genes have
been used to study influenza B virus evolution [8-10].
Two lineages have been identified as co-circulating since
1983: B/Victoria/2/87 (Vic87) and B/Yamagata/16/88
(Yam88) [11], and reassortants of the two lineages have
been observed since 2002 [12-18]. The increasing appear-
ance of reassortant influenza B was reported in Taiwan
from 2002 to 2005 [19].
We conducted phylogenetic analyses of HA and NA genes
from influenza B virus isolates collected from a group of
children complaining of severe headaches in north Tai-
wan between October 2006 and February 2007. Variants
were further tested using a hemagglutinin inhibition (HI)
test with a panel of anti-flu B antisera; our results indicate
incomplete inhibition. Data from an amino acid sequence
analysis of the HA protein showed greater sequence varia-
tion to B/Malaysia/2506/04-like viruses in 5 influenza B
variants (B/Taiwan/3009/06, B/Taiwan/3802/06, B/Tai-
wan/3804/06, B/Taiwan/3805/06, and B/Taiwan/3790/
06).
Methods
Subjects
Between October 2006 and February 2007, 452 throat
swabs from patients with symptoms related to respiratory
tract infection were collected at the clinical virology labo-
ratory of the Taipei Veterans General Hospital. This labo-
ratory has a contract with the Taiwan's Centers for Disease
Control and is responsible for the virological evaluation
of all the specimens sent from different hospitals in the
northern region of Taiwan. The epidemiological curve and
geographic distribution were shown in Figures 1 and 2.
The median age of 145 patients with influenza B infection
was 8 years old, with a range from 8 days to 14 years old
except that B/Taiwan/3807/06, B/Taiwan/3842/06, B/Tai-
wan/1575/07 and B/Taiwan/1540/07 were 19, 18, 23 and
43 years old respectively. Seventy-four patients are male
and seventy-one are female. To study the hemagglutinin
inhibition titers for the influenza virus B isolates, five
adult volunteers including four normal individuals and
one patient (P139) with impaired immune function were
recruited to receive vaccines containing A/New Caledo-
nia/20/99, A/Wisconsin/67/05 and B/Malaysia/2506/04
strains. Informed consent was obtained from all partici-
pants. Patient P139 described that he was incapable of
generating anti-hepatitis B virus (HBV) surface antibodies
after repeatedly inoculated with HBV vaccine. Serum sam-
ples were collected prior to and 3 months after vaccina-
tion.
Virus Isolation and Confirmation
Filtrates from transport medium containing throat swabs
were inoculated into Madin-Darby Canine Kidney
(MDCK) cells. HA tests with guinea pig red blood cells
were used to test the cultural supernatant for influenza B
viral infection. Infected cells were detected using an
IMAGEN™ influenza virus test kits (DaKo Cytomation
Ltd, Cambs, UK) contain fluorescein isothiocy-
anate(FITC) conjugated monoclonal antibodies which
bind specifically to influenza virus type B.
RNA Extraction and RT-PCR
Viral RNA was extracted from 140 μL of infected tissue cul-
ture fluid using a QIAamp Viral RNA mini Kit (QIAGEN
Inc., CA). Real-time PCR was performed with 5 μL RNA,
Taqman one-step RT-PCR master mix reagents (Roche,
New Jersey USA), 400 nM primer and 100 nM probe. The
primers and probe used were according to Garbino et al.
[20] and the cycling condition is 30 min at 48°C, 10 min
at 95°C, and 40 cycles of 15 seconds at 95°C and 1 min
at 60°C. In addition, 5 μL of eluted RNA were used for
amplification with a QIAGEN one-step reverse transcrip-
tion (RT)-PCR reagent. RT-PCR and sequencing for HA
and NA were performed according to Tsai et al. [19].
Nucleotide Sequence Analysis
DNA sequence analysis was performed using software
from the Wisconsin Genetics Computer Group (GCG)
[19,21,22]. All nucleotide sequences identified in this
study have been deposited in GenBank (accession num-
bers EU234376 to EU234451).
Phylogenetic Analysis
Alignment of the respective 739 and 251 base pairs of HA
and NA gene sequences was performed using the DNAS-
TAR MegAlign clustal method. Phylogenetic trees were
constructed using the neighbor-joining method based on
Kimura's 2-parameter distance matrix with 1000 boot-
strap replicates, using the MEGA (version 3.0) and
PHYLIP (version 3.6) software packages [23-25]. We used
MEGA for construction of neighbor-joining trees and
PHYLIP for parsimony and maximum-likelihood meth-BMC Research Notes 2009, 2:86 http://www.biomedcentral.com/1756-0500/2/86
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ods to verify the topology of taxas shown in the trees. In
this study, all trees are shown as the neighbor-joining tree
from MEGA.
Hemagglutinin Inhibition Test
HI testing of 2006–2007 samples was performed using
the World Health Organization (WHO) Influenza Rea-
gent Kit for identifying influenza isolates, produced and
distributed by WHO collaborating center for surveillance,
epidemiology and control of influenza in American Con-
tinent (CDC, USA) as described in the kit's manual. Refer-
ence strain samples consisted of distinct influenza B anti-
sera from four epidemics: B/Malaysia/2506/04 (B reassor-
tant lineage), B/Hong Kong/330/01 (Victoria lineage), B/
shanghai/361/02 (Yamagata lineage), and B/Sichuan/
379/99 (Yamagata lineage).
Results
Reassortant Influenza B Virus Epidemiology
Among HA screening tests positive cases from 452 speci-
mens, 145 (32%) were confirmed to have influenza B
infection using both real-time PCR and IFA test. The epi-
demiological curve and geographic distribution analyses
demonstrated that the influenza B infection reach the
peak in December 2006 and there were four outbreaks in
Yilan county located in the northern region of Taiwan:
outbreak I, 8 children from Jiaosi town; outbreak II, 7 stu-
dents from Shai-Jin Elementary School in Wujie town;
outbreak III, 5 students from Li-Tse Elementary School in
Wujie town; and outbreak IV, 5 children from Toucheng
town (Figures 1 and 2). Major symptoms included vomit,
rhinorrhea, myalgia, diarrhea, prostration, lethargy,
pharynegeal vesicles or ulcers, cough, sore throat, head-
ache, and fever (temperature > 38°C), with a duration of
1–2 weeks. Of the patients from Yilan county, all 25 were
in kindergarten or primary school, aged between 6 and 8
years old.
Phylogenetic Analysis
According to results obtained from phylogenetic analyses
of nearly full-length HA nucleotide sequences for the HA1
subunit (1100 nt) of influenza B virus isolates from 39
patients including 38 children and 1 adult (B/Taiwan/
3842/06), all isolates clustered with B/Malaysia/2506/04-
Data on influenza B virus outbreak in North Taiwan between October 2006 and February 2007 Figure 1
Data on influenza B virus outbreak in North Taiwan between October 2006 and February 2007. Of 452 clinical 
respiratory samples examined, 145 (32%) tested positive for a B/Malaysia/2506/04-like strain (B reassortant lineage). The data 
came from 4 outbreaks and 2 group samples: Outbreak I, 8 patients from Yilan, Jiaosi (YLJS); outbreak II, 7 patients from Shai-
Jin, Yilan, Wujie (YLWJ-SJ); outbreak III, 5 patients from Li-Tse, Yilan, Wujie (YLWJ-LT); outbreak IV, 5 patients from Yilan, 
Toucheng (YLTC); group 1, 110 patients from other clinics of CDVL; group 2, 10 patients from Taipei-VGH ordinary clinic.BMC Research Notes 2009, 2:86 http://www.biomedcentral.com/1756-0500/2/86
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HA with a bootstrap value of 96 (P < 0.01) (Figure 3). B/
Malaysia/2506/04 has been identified by the WHO as the
primary vaccine strain for the 2006–2007 flu season in the
northern hemisphere. Note that 4 variants (cluster I) in
outbreak II clustered on a single branch with a bootstrap
value of 79 and statistical p value < 0.01 (Figure 3). In
terms of NA genes, all 37 Taiwanese isolates were identi-
fied as belonging to the B reassortant lineage (P < 0.05)
except two isolates were not PCR amplified (Figure 4).
Variation in HA and NA Amino Acid Sequences
Compared to amino acid residues 22–234 of the B/Malay-
sia/2506/04 HA protein, most of the Taiwanese isolates
had only 2–3 changes. Exceptions included 1 strain from
outbreak I (B/Taiwan/3009/06, 9 amino acid changes)
and 4 variants (cluster I) from outbreak II (B/Taiwan/
3802/06, B/Taiwan/3804/06, B/Taiwan/3805/06, and B/
Taiwan/3790/06, with a combined total of 14 amino acid
changes) (Table 1). Conserved region results indicate that
amino acid residues 16–77 of the B/Malaysia/2506/04
NA protein originated in the previous season's Yamagata
lineage strain (data not shown).
HI Titers
We used a panel of 4 reference sheep antisera to test the HI
titers of 10 influenza B isolates; results are presented in
Table 2. The HI titers of the B/Malaysia/2506/04-sheep
antiserum to the Taiwanese influenza virus B strains
belonged to outbreaks III, IV and the sporadic influenza B
cases ranged from 1,280 to 2,560. In contrast, only 640 to
1,280 HI titers of the B/Malaysia/2506/04-sheep antise-
rum were identified as belonging to outbreak II. The
number of HI titers for the B/Hong Kong/330/01-sheep
antiserum ranged from 160 to 640. The smallest numbers
of HI titers were observed in the antisera against the two
virus isolates belonging to the Yamagata lineage.
Post-Vaccination Serum Antibody Responses
Pre- and post-immunized serum samples were collected
from 5 volunteers who had received the influenza vaccine
for purposes of evaluating HI titers; all 5 generated anti-
body titers between 160 and 640 to the virus variants in
outbreak II (Table 3). Of those 5, 3 showed 4 to 8-fold
increases in HI antibody titers. The seroconversion factor
was 1 for the patient diagnosed as immunologically
incompetent. Another patient who reported to have
received very few influenza vaccinations in the preceding
ten years had exceptionally low antibody titers in his pre-
immunized serum but an acceptable number following
immunization.
Discussion
At least three distinct variants of influenza B virus with ori-
gins in China have been collected from Taiwanese
patients since 2002: B/Shanghai/361/2002-like
(Yamagata lineage), B/Hong Kong/330/01-like (Victoria
lineage), and B/Hong Kong/1351/02-like (B reassortant
with Victoria-like HA and Yamagata-like NA genes)
[19,21,22]. We characterized influenza viruses isolated
form both children and adults living in north Taiwan
between October 2006 and February 2007 for purposes of
analyzing the antigenic properties and phylogenetic rela-
tionships of HA and NA genes from the influenza B virus
isolates. Our results suggest the increasing reappearance
of the VIC-HA/YAM-NA reassortant influenza B viruses
during this period, with most outbreaks affecting children
aged 6 to 8 years (Figures 1 and 2).
A total of 39 clinical isolates of reassortant influenza B
viruses were used for molecular evolutionary analyses of
HA and NA genes. Our results show that the HA genes
belonged to the B/Victoria/2/87 lineage (Figure 3). We
also found evidence of four outbreaks of reassortant influ-
enza B viruses in the B/Victoria/2/87 lineage among ele-
mentary school-aged children living in Taiwan's Yilan
County. Note the 4 variants (cluster I) in outbreak II that
are clustered on a single branch in Figure 2–supported by
a bootstrap value of 79%. The statistical P-value (P < 0.01)
indicate the cluster strains for significance. These viruses
were genetically similar to the B/Malaysia/2506/04 vac-
cine strain that was recommended as the vaccine candi-
date for the 2006–2007 flu season in the northern
hemisphere. Results from sequence analyses of NA genes
from the 37 Taiwan isolates indicate that they all
belonged to the B/Yamagata/16/88 lineage (Figure 4)–
that is, they clustered with two strains belonging to the B
reassortant lineage, the B/Malaysia/2506/04 vaccine
strain and B/Hong Kong/1351/02.
Approximate distribution of influenza B viruses analyzed for  this research Figure 2
Approximate distribution of influenza B viruses ana-
lyzed for this research.BMC Research Notes 2009, 2:86 http://www.biomedcentral.com/1756-0500/2/86
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A phylogenetic analysis of HA genes from influenza B virus isolates obtained between October 2006 and February 2007 Figure 3
A phylogenetic analysis of HA genes from influenza B virus isolates obtained between October 2006 and Feb-
ruary 2007. Dendrogram of 39 influenza B strains and 32 GenBank reference strains is based on 739 nucleotides (75 to 813) 
of the HA1 gene (neighbor-joining method with DNASTAR distance measure program; MEGA, Version 3.0). The linear 
unrooted phylogenetic dendrograms present the B/Lee/40 sequence as an outgroup. Branch length indicates genetic distance 
according to indicated distance scale (0.01, 1% difference). Bootstrap analysis percentages (n = 1000) for each branch are indi-
cated. The statistical p-values were labeled on each node (*P < 0.05 and **P < 0.01).BMC Research Notes 2009, 2:86 http://www.biomedcentral.com/1756-0500/2/86
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Phylogenetic analysis of NA genes from influenza B virus isolates obtained between October 2006 and February 2007 Figure 4
Phylogenetic analysis of NA genes from influenza B virus isolates obtained between October 2006 and Febru-
ary 2007. Dendrogram of 37 influenza B strains and 23 GenBank reference strains is based on 251 nucleotides (33 to 283) of 
the NA gene (neighbor-joining method with DNASTAR distance measure program; MEGA, Version 3.0). The linear unrooted 
phylogenetic dendrograms present the B/Lee/40 sequence as an outgroup. Branch length indicates genetic distance according 
to indicated distance scale (0.01, 1% difference). Bootstrap analysis percentages (n = 1000) for each branch are indicated. The 
statistical p-values were labeled on each node (*P < 0.05 and **P < 0.01).B
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Table 1: Variations in HA amino acid sequence in recent influenza B viruses of Victoria lineage in Taiwan during 2006.10-2007.02 influenza season.
Amino acid position
Outbreak Virus 
strain(s) 2
4
2
5
4
8
4
9
7
9
8
0
8
3
1
0
0
1
1
6
1
2
1
1
2
7
1
2
8
1
2
9
1
3
4
1
3
5
1
4
6
1
5
4
1
6
4
1
7
6
1
8
2
1
8
6
1
8
9
1
9
7
1
9
9
2
0
4
2
1
4
2
1
6
2
1
7
2
1
8
2
2
0
2
2
1
2
2
8
2
3
0
Reference 
strains
B/Malaysia/
2506/04
VNETARRDHTAENSYVADETDTNALTSANV T I G
B/Beijing/
243/97
KK I K PV T T
B/HK/330/
2001
KKR N K P E S T
B/TW/
N1582/02
KKR N E P E T
B/TW/
N384/03
KKR N E P I E T
B/TW/
N3688/04
PT
B/TW/
M251/05
VP T
B/TW/
S117/05
L PT
IB / T a i w a n /
3009/06
AP H K PH K TT
B/Taiwan/
3012/06
PT
B/Taiwan/
3014/06
PT
II B/Taiwan/
3802/06
PP Y A T F V V
B/Taiwan/
3804/06
PT G T V
B/Taiwan/
3805/06
PP T F A K A V
B/Taiwan/
3790/06
PP T F Y V
B/Taiwan/
3803/06
PT
B/Taiwan/
3791/06
PT
B/Taiwan/
3792/06
PT
III B/Taiwan/
3017/06
YP T
B/Taiwan/
3798/06
PT
B/Taiwan/
3801/06
PTB
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IV B/Taiwan/
3799/06
PT S
B/Taiwan/
3800/06
PT S
B/Taiwan/
3019/06
PT S
sporadic B/Taiwan/
3594/06*
PT
B/Taiwan/
3609/06
AP T
B/Taiwan/
3733/06
PS T
B/Taiwan/
3806/06
PT S
B/Taiwan/
3853/06
PT D
B/Taiwan/
3001/06
I
B/Taiwan/
3007/06
PT M
*: Sporadic variant strain the same as 11 isolates including B/Taiwan/3716/06, B/Taiwan/3744/06, B/Taiwan/3731/06, B/Taiwan/3764/06, B/Taiwan/3766/06, B/Taiwan/3796/06, B/Taiwan/3817/06, B/Taiwan/3842/06, B/Taiwan/3843/
06, B/Taiwan/3849/06, and B/Taiwan/1567/07.
Table 1: Variations in HA amino acid sequence in recent influenza B viruses of Victoria lineage in Taiwan during 2006.10-2007.02 influenza season. (Continued)BMC Research Notes 2009, 2:86 http://www.biomedcentral.com/1756-0500/2/86
Page 9 of 11
(page number not for citation purposes)
Compared to amino acid residues 22–234 of the B/Malay-
sia/2506/04 HA protein, most of the Taiwanese isolates
had only 2–3 changes. Exceptions included 1 strain from
outbreak I with 9 changes and 4 variants (cluster I) from
outbreak II with 14 changes (Table 1). Genetic variation
in this highly variant region suggests a potential for these
reassortant variants to cause future outbreaks.
We performed HI tests for the identification of HA in cir-
culating influenza B viruses. Our results show that the
majority of circulating influenza B viruses (i.e., B/Malay-
sia/2506/04-like viruses) collected between October 2006
to and February 2007 belonged to the B/Victoria/2/87 lin-
eage (Table 2). The data also indicate that the lowest HA
titers were observed with sheep antisera against the other
Table 2: Antigenic virus identification of different Influenza B viruses.
HI Antigen Typing (titer)
Outbreak Patient ID Number B/Malaysia/2506/04a B/Hong Kong/330/01b B/Shanghai/361/02c B/Sichuan/379/99c
II B/Taiwan/3802/06 640 320 10 10
B/Taiwan/3803/06 640 160 10 10
B/Taiwan/3805/06 1280 320 10 10
III B/Taiwan/3798/06 1280 320 10 10
IV B/Taiwan/3799/06 2560 320 10 10
Sporadic B/Taiwan/3853/06 1280 320 10 10
B/Taiwan/3716/06 1280 160 10 10
B/Taiwan/3733/06 2560 640 10 10
B/Taiwan/3594/06 2560 640 10 10
B/Taiwan/3001/06 2560 320 10 10
B/Malaysia/2506/04a 320
B/Hong Kong/330/01b 160
B/Shanghai/361/02c 1280
B/Sichuan/379/99c 160
aB reassortant lineage
bVictoria lineage
cYamagata lineage
Table 3: Comparison of Antibody Results and Seroconversion Factor for Reassortant Influenza B Viruses
HI antibody results (titer)
Outbreak Patient ID Number P004 P009 P109 P139 P182 PCb Seroconversion factorc
pred poste pre post pre post pre post pre post P004 P009 P109 P139 P182
II B/Taiwan/3802/06 80 320 80 640 40 160 160 160 10 640 2560 4 8 4 1 64
(Cluster I) B/Taiwan/3805/06 80 320 80 640 80 160 160 160 10 640 2560 4 8 2 1 64
III B/Taiwan/3798/06 20 160 40 160 20 80 40 40 10 160 1280 8 4 4 1 16
B/Taiwan/3594/06 40 320 40 320 40 320 80 80 10 160 5120 8 8 8 1 16
sporadic B/Taiwan/3853/06 20 160 80 160 40 160 80 80 10 160 1280 8 2 4 1 16
B/Taiwan/3001/06 20 160 40 320 20 80 40 40 < 10 80 2560 8 8 4 1 8
PCa (B/Malaysia) 40 160 80 160 20 80 40 40 10 80 640 4 2 4 1 8
aPositive control (B/Malaysia/2506/04) antigen (CDC, Atlanta, USA).
bPositive control (B/Malaysia/2506/04) reference sheep antiserum (CDC, Atlanta, USA).
cSeroconversion factor represents the number of fold-increase in Serum HI titer post-vaccination.
dPre-immune.
ePost-immune.BMC Research Notes 2009, 2:86 http://www.biomedcentral.com/1756-0500/2/86
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two isolates belonging to the Yamagata lineage. We used
a panel of serum samples from 5 patients who received
influenza vaccinations to test their ability to generate pro-
tective immunity against influenza B variants isolated
from young children living in Yilan county, using sero-
conversion factor as our criteria. Of the 5 patients, 4
showed a minimum of 4-fold increases in HI titers post-
vaccination; the seroconversion factor was 1 for the fifth
patient, who was later diagnosed as immunologically
incompetent (Table 3). These results suggest that the cur-
rent influenza vaccine is still effective in stimulating pro-
tective immunity against the influenza B variants that we
isolated [26-28]. Previously, Jian et al. reported a group of
influenza B viruses isolated in Taiwan during the 2004–
2005 and 2006–2007 epidemics [29]. In this study, we
identified a group of children, lived in the northern
regions of Taiwan, infected with influenza B virus variant.
Most of them had severe headache symptoms when they
had the virus infection. This has not been found by Jian et
al. In addition, we have performed "hemagglutinin inhi-
bition (HI) test" in our study (Table 2 and 3) which have
never been reported by Jian et al.
The gene variable analysis of influenza viruses can provide
information for epidemic and pandemic outbreak surveil-
lance and determination of vaccine strain selection. In this
study, we have shown data suggesting that the contempo-
rary vaccine was still effective in stimulating protective
immunity against the influenza B variants that we iso-
lated. Therefore, continuous monitoring of emerging
influenza B virus variants is vital to successful control not
only locally, but also internationally.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
LYM performed the analysis of the data and drafted the
manuscript. WSF and LCM revised the manuscript and did
supplementary analysis. CKH, CYJ and LWT participated
in the design of the study. CYMA participated in the
design, revised the manuscript and coordination of the
study. They all approved the final version of the manu-
script.
Acknowledgements
This study was supported in part by grants from the Republic of China 
(ROC) National Science Council (no. NSC 97-2321-B-010-003), the ROC 
Centers for Disease Control (no. CDC-96-RD-003), and the Ministry of 
Education, Aim for the Top University Plan. We thank staffs from the 
Genome Research Center at National Yang-Ming University for their tech-
nical support. We also thank colleagues at the AIDS Prevention and 
Research Center of National Yang-Ming University and Division of Clinical 
Virology, Department of Pathology and Laboratory Medicine, of Taipei Vet-
erans General Hospital for helpful discussions and support.
References
1. Haaheim LR, Pattison JR, Whitley RJ: Influenzaviruses.  In A practical
guide to Clinical Virology 2nd edition. Edited by: Haaheim LR. Oxford,
England: John Wiley & Sons Ltd; 2002:67-74. 
2. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA: Orthomyxovi-
ruses: Medical Microbiology.  5th edition. Philadelphia, PA,
USA:ELSEVIER MOSBY; 2005:609-617. 
3. Balicer RD, Huerta M, Levy Y, Davidovitch N, Grotto I: Influenza
outbreak control in confined settings.  Emerg Infect Dis 2005,
11:579-583.
4. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ,
Likos AM, Posey DL, Klimov A, Lindstrom SE, Balish A, Medina MJ,
Wallis TR, Guarner J, Paddock CD, Shieh WJ, Zaki SR, Sejvar JJ, Shay
DK, Harper SA, Cox NJ, Fukuda K, Uyeki TM: Influenza-associ-
ated deaths among children in the United States, 2003–2004.
N Engl J Med 2005, 353:2559-2567.
5. Bosis S, Esposito S, Niesters HGM, Zuccotti GV, Marseglia G, Lanari
M, Zuin G, Pelucchi C, Osterhaus ADME, Principi N: Role of respi-
ratory pathogens in infants hospitalized for a first episode of
wheezing and their impact on recurrences.  Clin Microbiol Infect
2008, 14:677-684.
6. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B,
Strauss E: Orthomyxoviridae: The Viruses and their replica-
tion.  In Fields Virology 5th edition. Edited by: Palese P, Shaw ML. Phil-
adelphia, PA, USA: LIPPINCOTT WILLIAMS & WILKINS;
2007:1647-1689. 
7. Weitzel T, Schnabel E, Dieckmann S, Borner U, Schweiger B: Evalu-
ation of a new point-of-care test for influenza A and B virus
in travelers with influenza-like symptoms.  Clin Microbiol Infect
2007, 13:665-669.
8. Nerome R, Hiromoto Y, Sugita S, Tanabe N, Ishida M, Matsumoto M,
Lindstrom SE, Takahashi T, Nerome K: Evolutionary characteris-
tics of influenza B virus since its first isolation in 1940:
dynamic circulation of deletion and insertion mechanism.
Arch Virol 1998, 143:1569-1583.
9. McCullers JA, Wang GC, He S, Webster RG: Reassortment and
insertion-deletion are strategies for the evolution of influ-
enza B viruses in nature.  J Virol 1999, 73:7343-7348.
10. Xu X, Lindstrom SE, Shaw MW, Smith CB, Hall HE, Mungall BA, Sub-
barao K, Cox NJ, Klimov A: Reassortment and evolution of cur-
rent human influenza A and B viruses.  Virus Res 2004,
103:55-60.
11. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K:
Cocirculation of two distinct evolutionary lineages of influ-
enza type B virus since 1983.  Virology 1990, 175:59-68.
12. Rota PA, Hemphill ML, Whistler T, Regnery HL, Kendal AP: Anti-
genic and genetic characterization of the haemagglutinins of
recent cocirculating strains of influenza B virus.  J Gen Virol
1992, 73(Pt 10):2737-2742.
13. Chi XS, Bolar TV, Zhao P, Rappaport R, Cheng SM: Cocirculation
and evolution of two lineages of influenza B viruses in europe
and Israel in the 2001–2002 season.  J Clin Microbiol 2003,
41:5770-5773.
14. Ansaldi F, D'Agaro P, De FD, Puzelli S, Lin YP, Gregory V, Bennett M,
Donatelli I, Gasparini R, Crovari P, Hay A, Campello C: Molecular
characterization of influenza B viruses circulating in north-
ern Italy during the 2001–2002 epidemic season.  J Med Virol
2003, 70:463-469.
15. Puzelli S, Frezza F, Fabiani C, Ansaldi F, Campitelli L, Lin YP, Gregory
V, Bennett M, D'Agaro P, Campello C, Crovari P, Hay A, Donatelli I:
Changes in the hemagglutinins and neuraminidases of
human influenza B viruses isolated in Italy during the 2001–
02, 2002–03, and 2003–04 seasons.  J Med Virol 2004, 74:629-640.
16. Ansaldi F, Icardi G, Gasparini R, Campello C, Puzelli S, Bella A, Don-
atelli I, Salmaso S, Crovari P: New A/H3N2 influenza variant: a
small genetic evolution but a heavy burden on the Italian
population during the 2004–2005 season.  J Clin Microbiol 2005,
43:3027-3029.
17. Motta FC, Siqueira MM, Lugon AK, Straliotto SM, Fernandes SB,
Krawczuk MM: The reappearance of Victoria lineage influenza
B virus in Brazil, antigenic and molecular analysis.  J Clin Virol
2006, 36:208-214.
18. Chen JM, Guo YJ, Wu KY, Guo JF, Wang M, Dong J, Zhang Y, Li Z,
Shu YL: Exploration of the emergence of the Victoria lineage
of influenza B virus.  Arch Virol 2007, 152:415-422.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Research Notes 2009, 2:86 http://www.biomedcentral.com/1756-0500/2/86
Page 11 of 11
(page number not for citation purposes)
19. Tsai HP, Wang HC, Kiang D, Huang SW, Kuo PH, Liu CC, Su IJ, Wang
JR: Increasing appearance of reassortant influenza B virus in
Taiwan from 2002 to 2005.  J Clin Microbiol 2006, 44:2705-2713.
20. Garbino J, Gerbase MW, Wunderli W, Deffernez C, Thomas Y,
Rochat T, Ninet B, Schrenzel J, Yerly S, Perrin L, Soccal PM, Laurent
N, Kaiser L: Lower respiratory viral illnesses improved diag-
nosis by molecular methods and clinical impact.  Am J Respir
Crit Care Med 2004, 170:1197-1203.
21. Lin JH, Chiu SC, Shaw MW, Lin YC, Lee CH, Chen HY, Klimov A:
Characterization of the epidemic influenza B viruses isolated
during 2004–2005 season in Taiwan.  Virus Res 2007,
124:204-211.
22. Chen GW, Shih SR, Hsiao MR, Chang SC, Lin SH, Sun CF, Tsao KC:
Multiple genotypes of influenza B viruses cocirculated in Tai-
wan in 2004 and 2005.  J Clin Microbiol 2007, 45:1515-1522.
23. Kumar S, Tamura K, Nei M: MEGA3: integrated software for
molecular evolutionary genetics analysis and sequence align-
ment.  Brief Bioinform 2004, 5:150-163.
24. Hillis DM, Bull JJ: An empirical test of bootstrapping confidence
in phylogenetic analysis.  Syst Biol 1993, 42:182-192.
25. Felsenstein J: PHYLIP–Phylogeny Inference Package (version
3.2).  Cladistics 1989, 5:166.
26. Holm MV, Blank PR, Szucs TD: Trends in influenza vaccination
coverage rates in Germany over five seasons from 2001 to
2006.  BMC Infect Dis 2007, 7:144-151.
27. Madani TA, Ghabrah TM: Meningococcal, influenza virus, and
hepatitis B virus vaccination coverage level among health
care workers in Hajj.  BMC Infect Dis 2007, 7:80-85.
28. Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Hoecke CV,
Howe BJ, Dubin G: Serum antibody responses after intrader-
mal vaccination against influenza.  N ENGL J MED 2004,
351:2286-94.
29. Jian JW, Lai CT, Kuo CY, Kuo SHS, Hsu LC, Chen PJ, Wu HS, Liu MT:
Genetic analysis and evaluation of the reassortment of influ-
enza B viruses isolated in Taiwan during the 2004–2005 and
2006–2007 epidemics.  Virus research 2008, 131:243-249.